This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • PEACE-3 Trial
      • PROfound Trial
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • VISION Trial
    • mHSPC
      • ARANOTE Trial
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • nmCSPC
      • EMBARK Trial
    • PSMA PET Imaging
      • COBRA Trial
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • ADSTILADRIN
      • ANKTIVA
      • Bladder Cancer Detection
      • CORE-001 Study
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Shilpa Gupta, MD
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
        • Endourology
          • Endourology
            Jaime Landman, MD
      • Prostate Cancer
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • Decipher Genomic Classifier
        • Imaging Center
          Phillip Koo, MD
        • mHSPC
          Neeraj Agarwal, FASCO, MD
        • nmCRPC
          Zachary Klaassen, MD, MSc
        • mCRPC Treatment
          A. Oliver Sartor, MD
        • PSMA-Targeted Therapy
        • Advanced Prostate Cancer
          Zachary Klaassen, MD, MSc
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular Cancer
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Pelvic Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Medical Education
      • Covid-19
      • The Prostate Cancer Foundation
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
      • Practice Guidelines Reviews
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Testicular Cancer
      • Endourology
    • Pelvic Health & Reconstruction
      • Pelvic Health & Reconstruction
  • Trials in Progress
    • Trials in Progress
      • Bladder Cancer
        • BOND-003 Cohort P
        • CORE-008
        • IMMORTAL
        • PIVOT-006
      • Kidney Cancer
        • RadiCal
        • SAMURAI
    • Middle Side
      • Prostate Cancer
        • ARAMON
        • ARASEC
        • ARASTEP
        • CLARIFY
        • ECLIPSE
        • ESCAPE
        • FORT
    • Right Side
      • Prostate Cancer
        • METANOVA
        • NRG-GU 0101
        • PROMISE
        • RTIRE
        • SECuRE
        • SHORTER
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • SUO 2024
      • SCS AUA 2024
      • ASTRO 2024
      • IBCN 2024
      • ESMO 2024
    • All Conferences
      • View All
    • Quick Takes
      • ESMO 2024
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology

Renal Cancer

Recent Abstracts
DGU 2011 - Histologic subtypes of renal cell carcinoma demonstrate different activation of the mTOR pathway - Session Highlights September 23, 2011
Emerging targeted therapies in metastatic renal cell carcinoma - Abstract September 22, 2011
Immunotherapy of kidney cancer - Abstract September 22, 2011
Immunotherapy and targeted therapy combinations in renal cancer - Abstract September 22, 2011
DGU 2011 - Sorafenib (SOR) dosage patterns in > 4600 patients with renal cell carcinoma, including the elderly and patients treated for > 12 months: Results from an integrated database of 8 company-sponsored trials - Session Highlights September 22, 2011
DGU 2011 - Intrinsic resistance to treatment with tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma - Session Highlights September 22, 2011
DGU 2011 - Nephron-sparing surgery in patients with renal tumors >7 cm: Functional and oncological outcome - Session Highlights September 22, 2011
Diffusion-weighted magnetic resonance imaging in the differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma - Abstract September 21, 2011
miR-21 modulates cell apoptosis by targeting multiple genes in renal cell carcinoma - Abstract September 21, 2011
Graft reconstruction of inferior vena cava for renal cell carcinoma stage pT3b or greater - Abstract September 21, 2011
Decompressive surgery in combination with preoperative transcatheter arterial embolization: Successful improvement of ambulatory function in renal cell carcinoma patients with metastatic extradural spinal cord compression - Abstract September 20, 2011
Retrograde venous invasion in renal cell carcinoma: A complication of sinus vein and main renal vein invasion - Abstract September 20, 2011
Treatment-related optimism protects quality of life in a phase II clinical trial for metastatic renal cell carcinoma - Abstract September 20, 2011
Renal cell carcinoma metastasis to the ciliary body responds to proton beam radiotherapy: A case report - Abstract September 19, 2011
Systemic therapies for metastatic renal cell carcinoma in older adults - Abstract September 16, 2011
Efficacy of large doses of IL-2-activated human leukocyte antigen haploidentical peripheral blood stem cells on refractory metastatic renal cell carcinoma - Abstract September 16, 2011
Nephron sparing surgery for synchronous bilateral nephroblastoma involving the renal hilus - Abstract September 16, 2011
Biopsy-confirmed de novo renal cell carcinoma (RCC) in renal grafts: A single-centre management experience in a 2396 recipient cohort - Abstract September 15, 2011
Incidence and risk of congestive heart failure in patients with renal and nonrenal cell carcinoma treated with sunitinib - Abstract September 15, 2011
Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma - Abstract September 14, 2011
Page 440 of 456
  • Start
  • Prev
  • 435
  • 436
  • 437
  • 438
  • 439
  • 440
  • 441
  • 442
  • 443
  • 444
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2024 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free